Free Trial

DiaMedica Therapeutics (DMAC) Insider Trading & Ownership

DiaMedica Therapeutics logo
$5.31 -1.10 (-17.16%)
(As of 11:24 AM ET)

DiaMedica Therapeutics (NASDAQ:DMAC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.20%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$3 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get DMAC Insider Trade Alerts

Want to know when executives and insiders are buying or selling DiaMedica Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

DMAC Insider Buying and Selling by Quarter

DiaMedica Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/28/2024Koch Thomas VonMajor ShareholderBuy1,200,000$2.50$3,000,000.00  
(Data available from 1/1/2013 forward)

DMAC Insider Trading Activity - Frequently Asked Questions

The list of insiders at DiaMedica Therapeutics includes David J Wambeke, Dietrich John Pauls, Koch Thomas Von, Randall Michael Giuffre, and Scott Kellen. Learn more on insiders at DMAC.

7.20% of DiaMedica Therapeutics stock is owned by insiders. Learn more on DMAC's insider holdings.

The following insiders have purchased DMAC shares in the last 24 months: David J Wambeke ($900,003.24), Dietrich John Pauls ($49,997.17), Koch Thomas Von ($7,999,999.20), Randall Michael Giuffre ($254,150.00), and Scott Kellen ($39,100.00).

Insiders have purchased a total of 3,265,489 DMAC shares in the last 24 months for a total of $9,243,249.61 bought.

DiaMedica Therapeutics Key Executives

  • Mr. Dietrich John Pauls MBAMr. Dietrich John Pauls MBA (Age 53)
    President, CEO & Director
    Compensation: $818.61k
  • Mr. Scott Kellen CPA (Age 59)
    CFO & Corporate Secretary
    Compensation: $485.43k
  • Dr. Kirsten L. Gruis M.D. (Age 51)
    M.S., Independent Consultant
    Compensation: $449.29k
  • Dr. Ambarish Shah Ph.D.
    Chief Technology Officer
  • Mr. Dominic R. Cundari (Age 73)
    Chief Commercial Officer
  • Mr. David J. Wambeke (Age 40)
    Chief Business Officer
  • Dr. Lorianne K. Masuoka M.D. (Age 63)
    Chief Medical Officer


This page (NASDAQ:DMAC) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners